Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06562751Completed

Developing an Intervention to Help Nurses Improve Sexual Healthcare in Men With Inflammatory Bowel Disease

Role: collaborator

NCT07076017Not ApplicableActive Not Recruiting

Dry-land Strength and Conditioning for Competitive Youth Swimmers

Role: lead

NCT06874699Not ApplicableCompleted

Evaluation of the Exercise for Wellbeing Pathway at York St John University

Role: lead

NCT06400212Not ApplicableCompleted

CytoHealth - A Study of the Inflammatory Response to Exercise

Role: collaborator

NCT04057274Not ApplicableUnknown

Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth

Role: collaborator

NCT02505503Not ApplicableCompleted

York Study of Unloading Shoes for Vascular Intermittent Claudication

Role: collaborator

All 6 trials loaded